BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16791827)

  • 1. Cystic fibrosis enters the proteomics scene: new answers to old questions.
    Ollero M; Brouillard F; Edelman A
    Proteomics; 2006 Jul; 6(14):4084-99. PubMed ID: 16791827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic biomarker discovery for the monogenic disease cystic fibrosis.
    Penque D
    Expert Rev Proteomics; 2007 Apr; 4(2):199-209. PubMed ID: 17425456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of the "NADPH oxidases" (NOX/DUOX) family in cystic fibrosis.
    Pongnimitprasert N; El-Benna J; Foglietti MJ; Gougerot-Pocidalo MA; Bernard M; Braut-Boucher F
    Ann Biol Clin (Paris); 2008; 66(6):621-9. PubMed ID: 19091660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New concepts of pathophysiology and therapy in cystic fibrosis].
    Hirche TO; Loitsch S; Smaczny C; Wagner TO
    Pneumologie; 2005 Nov; 59(11):811-8. PubMed ID: 16385442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic and ionomic profiling reveals significant alterations of protein expression and calcium homeostasis in cystic fibrosis cells.
    Ciavardelli D; D'Orazio M; Pieroni L; Consalvo A; Rossi C; Sacchetta P; Di Ilio C; Battistoni A; Urbani A
    Mol Biosyst; 2013 Jun; 9(6):1117-26. PubMed ID: 23609890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics techniques for cystic fibrosis research.
    Roxo-Rosa M; Davezac N; Bensalem N; Majumder M; Heda GD; Simas A; Penque D; Amaral MD; Lukacs GL; Edelman A
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():85-9. PubMed ID: 15463934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein expression increases ATP release in respiratory cystic fibrosis cells.
    Naumann N; Siratska O; Gahr M; Rösen-Wolff A
    J Cyst Fibros; 2005 Sep; 4(3):157-68. PubMed ID: 15964250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative differential proteomics of cystic fibrosis cell models by SILAC (stable isotope labelling in cell culture).
    Guerrera IC; Ollero M; Vieu DL; Edelman A
    Methods Mol Biol; 2011; 742():213-25. PubMed ID: 21547735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR.
    Bhattacharyya S; Look D; Tobacman JK
    Clin Chim Acta; 2007 May; 380(1-2):122-7. PubMed ID: 17324393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new model of cystic fibrosis pathology: lack of transport of glutathione and its thiocyanate conjugates.
    Childers M; Eckel G; Himmel A; Caldwell J
    Med Hypotheses; 2007; 68(1):101-12. PubMed ID: 16934416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFTR in cystic fibrosis and cholera: from membrane transport to clinical practice.
    Goodman BE; Percy WH
    Adv Physiol Educ; 2005 Jun; 29(2):75-82. PubMed ID: 15905150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel mutation of CFTR gene in a Korean patient with cystic fibrosis.
    Ko JM; Kim GH; Kim KM; Hong SJ; Yoo HW
    J Korean Med Sci; 2008 Oct; 23(5):912-5. PubMed ID: 18955805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
    Ostrowski LE; Yin W; Diggs PS; Rogers TD; O'Neal WK; Grubb BR
    Gene Ther; 2007 Oct; 14(20):1492-501. PubMed ID: 17637798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
    Alibakhshi R; Zamani M
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathophysiologic mechanisms of cystic fibrosis lung disease.
    Soferman R
    Isr Med Assoc J; 2006 Jan; 8(1):44-8. PubMed ID: 16450752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
    Marcet B; Boeynaems JM
    Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misfolding of the cystic fibrosis transmembrane conductance regulator and disease.
    Cheung JC; Deber CM
    Biochemistry; 2008 Feb; 47(6):1465-73. PubMed ID: 18193900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.